These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9670055)

  • 1. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1).
    Kurts C; Heath WR; Kosaka H; Miller JF; Carbone FR
    J Exp Med; 1998 Jul; 188(2):415-20. PubMed ID: 9670055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney protection against autoreactive CD8(+) T cells distinct from immunoprivilege and sequestration.
    Kurts C; Klebba I; Davey GM; Koch KM; Miller JF; Heath WR; Floege J
    Kidney Int; 2001 Aug; 60(2):664-71. PubMed ID: 11473649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells.
    Kurts C; Kosaka H; Carbone FR; Miller JF; Heath WR
    J Exp Med; 1997 Jul; 186(2):239-45. PubMed ID: 9221753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cells directly tolerize CD8(+) T cells.
    Bennett SR; Carbone FR; Toy T; Miller JF; Heath WR
    J Exp Med; 1998 Dec; 188(11):1977-83. PubMed ID: 9841912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity.
    Kurts C; Heath WR; Carbone FR; Kosaka H; Miller JF
    Novartis Found Symp; 1998; 215():172-81; discussion 181-90. PubMed ID: 9760579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive class I-restricted exogenous presentation of self antigens in vivo.
    Kurts C; Heath WR; Carbone FR; Allison J; Miller JF; Kosaka H
    J Exp Med; 1996 Sep; 184(3):923-30. PubMed ID: 9064352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1).
    Reich A; Körner H; Sedgwick JD; Pircher H
    Eur J Immunol; 2000 Feb; 30(2):678-82. PubMed ID: 10671226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
    Martin-Orozco N; Wang YH; Yagita H; Dong C
    J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.
    Liu W; Evanoff DP; Chen X; Luo Y
    J Immunol; 2007 Jan; 178(1):539-46. PubMed ID: 17182594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
    Keir ME; Freeman GJ; Sharpe AH
    J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells.
    Lees JR; Charbonneau B; Swanson AK; Jensen R; Zhang J; Matusik R; Ratliff TL
    Immunology; 2006 Feb; 117(2):248-61. PubMed ID: 16423061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
    Shibaki A; Sato A; Vogel JC; Miyagawa F; Katz SI
    J Invest Dermatol; 2004 Jul; 123(1):109-15. PubMed ID: 15191550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
    Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
    Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired pMHC I complexes greatly enhance CD4(+) Th cell's stimulatory effect on CD8(+) T cell-mediated diabetes in transgenic RIP-mOVA mice.
    Ahmed KA; Xie Y; Zhang X; Xiang J
    Cell Mol Immunol; 2008 Dec; 5(6):407-15. PubMed ID: 19118506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim.
    Davey GM; Kurts C; Miller JF; Bouillet P; Strasser A; Brooks AG; Carbone FR; Heath WR
    J Exp Med; 2002 Oct; 196(7):947-55. PubMed ID: 12370256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas (CD95/APO-1) limits the expansion of T lymphocytes in an environment of limited T-cell antigen receptor/MHC contacts.
    Fortner KA; Lees RK; MacDonald HR; Budd RC
    Int Immunol; 2011 Feb; 23(2):75-88. PubMed ID: 21266499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.